Daiwa Securities Group »

Lyell Immunopharma shares owned by Daiwa Securities Group

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Daiwa Securities Group from 13F filings

Historical chart of Daiwa Securities Group investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Daiwa Securities Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Daiwa Securities Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $999 45 22.22
2025-06-30 $0 45 0.00

More positions owned by Daiwa Securities Group

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Welltower Inc Com reit (WELL)
Netflix Common stock (NFLX)
Digital Realty Trust (DLR)
Crowdstrike Hldgs Cl A (CRWD)
Servicenow (NOW)
Prologis (PLD)
Invitation Homes (INVH)
Global X Fds Conscious Cos (KRMA)

View all positions for Daiwa Securities Group

Top funds holding Lyell Immunopharma

Arch Venture Corp
MWG Management
Foresite Capital Management IV
Vanguard Group
Orland Properties
Almitas Capital
Foresite Capital Management V
venBio Partners
Citadel Advisors
Alphabet
BlackRock
Sc China Holding
Geode Capital Management
Millennium Management
Rbf Capital

View all funds holding Lyell Immunopharma